|
Craig K. Trask brings to Meritage Partners over 20 years of successful strategic development and merger and acquisition experience with publicly traded companies in the clinical laboratory and biotechnology industries. Mr. Trask experience structuring complex business transactions and his strong working knowledge of general accounting practices and acquisition related due-diligence make him a strong resource to Meritage Partner's management and consultants.From 1996 to 2001 Mr. Trask held the position of Vice President of Strategic Development with IMPATH, Inc., a publicly traded company managing businesses related to cancer diagnosis, prognosis, tumor registry, and patient information. During his five-year tenure with IMPATH's, he was responsible for all business development and merger and acquisition related activities. IMPATH's successful acquisition strategy helped grow the company from $12MM in sales in 1996, to a market capitalization of over $1 billion by 2000. From 1990-1996 he held the position of Vice President of Hospital Ventures and Director of Business Development for Quest-Unilab, Inc (ULB-NASDAQ)Mr. Trask holds a Business Degree from CSUF, with graduate studies from Cambridge University, UK. | 